Hereditary nephropathy, not elsewhere classified with diffuse mesangial proliferative glomerulonephritis
ICD-10 N07.3 is a billable code used to indicate a diagnosis of hereditary nephropathy, not elsewhere classified with diffuse mesangial proliferative glomerulonephritis.
N07.3 refers to a specific type of hereditary nephropathy characterized by diffuse mesangial proliferative glomerulonephritis. This condition is often associated with genetic mutations that affect kidney function, leading to proteinuria and potential progression to chronic kidney disease. Patients typically present with isolated proteinuria, which may be detected during routine urinalysis. The diffuse mesangial proliferation indicates an increase in mesangial cells within the glomeruli, which can be identified through renal biopsy. This condition is not classified under other specific nephropathies, making it essential for accurate coding to ensure proper management and treatment. Genetic testing may be warranted to identify specific hereditary factors contributing to the nephropathy, guiding treatment options and family counseling. The complexity of this condition lies in its genetic basis and the need for thorough documentation to support the diagnosis and any associated treatments.
Detailed renal function tests, biopsy results, and genetic testing documentation.
Patients presenting with unexplained proteinuria or family history of kidney disease.
Ensure clear documentation of hereditary factors and any associated symptoms.
Genetic testing results and family history documentation.
Patients undergoing genetic counseling for hereditary kidney disease.
Document the rationale for genetic testing and results interpretation.
Used when a renal biopsy is performed to confirm diffuse mesangial proliferation.
Pathology report detailing findings and correlation with clinical diagnosis.
Nephrologists should ensure biopsy results are clearly linked to the diagnosis.
Genetic testing is crucial in N07.3 as it helps identify specific hereditary factors contributing to the nephropathy, guiding treatment options and informing family members about potential risks.
